Return on Investments: An indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity. Calculated as: Income from Continuing Operations / (Total Long-Term Debt + Shareholders Equity)
Oramed Pharmaceuticals Inc. (ORMP) had Return on Investments of -13.14% for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-19.06M |
|
-- |
|
-- |
|
$12.78M |
|
$-12.78M |
|
$-3.14M |
|
$-15.92M |
|
$-15.92M |
|
$-19.10M |
|
$-19.10M |
|
$-19.10M |
|
$-19.10M |
|
$-12.78M |
|
$-12.59M |
|
40.83M |
|
40.83M |
|
$-0.48 |
|
$-0.48 |
|
| Balance Sheet Financials | |
$143.22M |
|
$0.70M |
|
$12.06M |
|
$155.28M |
|
$5.68M |
|
-- |
|
$4.25M |
|
$9.93M |
|
$145.35M |
|
$145.35M |
|
$145.35M |
|
39.92M |
|
| Cash Flow Statement Financials | |
$-8.41M |
|
$105.82M |
|
$-52.04M |
|
$9.05M |
|
$54.42M |
|
$45.37M |
|
$4.05M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
25.19 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-8.43M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-13.14% |
|
-13.14% |
|
-12.30% |
|
|
Return on Investments |
-13.14% |
$3.64 |
|
$-0.21 |
|
$-0.21 |
|